Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT01378715
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT01378715
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia, Slovakia
- Registry status
- Unknown status
Technical summary
Registry record NCT01378715. Randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
- Acronym
- TIPS-3
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- University Hospital, Motol
Record details
- Record id
cardio:ct-nct01378715- Content hash
5ae61e5ecd2018ac12dfa8f3740696c6c7fcea51f1702971826d21a53f8f3671